Extended treatment with single-agent ibrutinib at the 420 mg dose leads to durable responses in chronic lymphocytic leukemia/small lymphocytic lymphoma, 2017---cubierta (Seven E. Coutré); página OF 1 (Stanford Cancer Center, Stanford University School of Medicine, Stanford, California)

2016 ASH, selected poster Poster 4383, 2016---portada (Steven Coutré)